Literature DB >> 33322307

Health-Related Quality of Life and Health Service Use among Multimorbid Middle-Aged and Older-Aged Adults in China: A Cross-Sectional Study in Shandong Province.

Qinfeng Zhao1,2, Jian Wang3,4, Stephen Nicholas5,6,7,8,9, Elizabeth Maitland10, Jingjie Sun11, Chen Jiao1,2, Lizheng Xu12,13, Anli Leng14.   

Abstract

(1) Background: The management of multiple chronic diseases challenges China's health system, but current research has neglected how multimorbidity is associated with poor health-related quality of life (HRQOL) and high health service demands by middle-aged and older adults. (2)
Methods: A cross-sectional study was conducted in Shandong province, China in 2018 across three age groups: Middle-aged (45 to 59 years), young-old (60 to 74 years), and old-old (75 or above years). The information about socio-economic, health-related behaviors, HRQOL, and health service utilization was collected via face-to-face structured questionnaires. The EQ-5D-3L instrument, comprising a health description system and a visual analog scale (VAS), was used to measure participants' HRQOL, and χ2 tests and the one-way ANOVA test were used to analyze differences in socio-demographic factors and HRQOL among the different age groups. Logistic regression models estimated the associations between lifestyle factors, health service utilization, and multimorbidity across age groups. (3)
Results: There were 17,867 adults aged 45 or above in our sample, with 9259 (51.82%) female and 65.60% living in rural areas. Compared with the middle-aged adults, the young-old and old-old were more likely to be single and to have a lower level of education and income, with the old-old having lower levels than the young-old (P < 0.001). We found that 2465 (13.80%) suffered multimorbidities of whom 75.21% were older persons (aged 60 or above). As age increased, both the mean values of EQ-5D utility and the VAS scale decreased, displaying an inverse trend to the increase in the number of chronic diseases (P < 0.05). Ex-smokers and physical check-ups for middle or young-old respondents and overweight/obesity for all participants (P < 0.05) were positively correlated with multimorbidity. Drinking within the past month for all participants (P < 0.001), and daily tooth-brushing for middle (P < 0.05) and young-old participants (P < 0.001), were negatively associated with multimorbidity. Multimorbidities increased service utilization including outpatient and inpatient visits and taking self-medicine; and the probability of health utilization was the lowest for the old-old multimorbid patients (P < 0.001). (4) Conclusions: The prevalence and decline in HRQOL of multimorbid middle-aged and older-aged people were severe in Shandong province. Old patients also faced limited access to health services. We recommend early prevention and intervention to address the prevalence of middle-aged and old-aged multimorbidity. Further, the government should set-up special treatment channels for multiple chronic disease sufferers, improve medical insurance policies for the older-aged groups, and set-up multiple chronic disease insurance to effectively alleviate the costs of medical utilization caused by economic pressure for outpatients and inpatients with chronic diseases.

Entities:  

Keywords:  China; middle-aged and old-aged adults; multimorbidity

Year:  2020        PMID: 33322307      PMCID: PMC7764479          DOI: 10.3390/ijerph17249261

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  39 in total

1.  Prevalence and distribution of risk factors for non-communicable chronic diseases among adults from Lages city, south of Brazil, 2007.

Authors:  Giana Zarbato Longo; Janaina das Neves; Teresa Gontijo de Castro; Márcia Regina de Oliveira Pedroso; Izabella Barison Matos
Journal:  Rev Bras Epidemiol       Date:  2011-12

Review 2.  Multimorbidity and mortality in older adults: A systematic review and meta-analysis.

Authors:  Bruno Pereira Nunes; Thaynã Ramos Flores; Grégore Iven Mielke; Elaine Thumé; Luiz Augusto Facchini
Journal:  Arch Gerontol Geriatr       Date:  2016-08-02       Impact factor: 3.250

3.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

Authors:  Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie
Journal:  Lancet       Date:  2012-05-10       Impact factor: 79.321

Review 4.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

5.  Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey.

Authors:  Calypse B Agborsangaya; Darren Lau; Markus Lahtinen; Tim Cooke; Jeffrey A Johnson
Journal:  BMC Public Health       Date:  2012-03-19       Impact factor: 3.295

6.  Multimorbidity prevalence and pattern in Indonesian adults: an exploratory study using national survey data.

Authors:  Mohammad Akhtar Hussain; Rachel R Huxley; Abdullah Al Mamun
Journal:  BMJ Open       Date:  2015-12-09       Impact factor: 2.692

7.  The contribution of risk factors to socioeconomic inequalities in multimorbidity across the lifecourse: a longitudinal analysis of the Twenty-07 cohort.

Authors:  Srinivasa Vittal Katikireddi; Kathryn Skivington; Alastair H Leyland; Kate Hunt; Stewart W Mercer
Journal:  BMC Med       Date:  2017-08-24       Impact factor: 8.775

Review 8.  Periodontal Pathogens as Risk Factors of Cardiovascular Diseases, Diabetes, Rheumatoid Arthritis, Cancer, and Chronic Obstructive Pulmonary Disease-Is There Cause for Consideration?

Authors:  Denis Bourgeois; Camille Inquimbert; Livia Ottolenghi; Florence Carrouel
Journal:  Microorganisms       Date:  2019-10-09

9.  Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis.

Authors:  Xue-Zheng Li; Feng Jin; Jian-Guo Zhang; Yun-Feng Deng; Wei Shu; Jing-Min Qin; Xin Ma; Yu Pang
Journal:  Infect Dis Poverty       Date:  2020-06-29       Impact factor: 4.520

10.  Multimorbidity prevalence in the general population: the role of obesity in chronic disease clustering.

Authors:  Calypse B Agborsangaya; Emmanuel Ngwakongnwi; Markus Lahtinen; Tim Cooke; Jeffrey A Johnson
Journal:  BMC Public Health       Date:  2013-12-10       Impact factor: 3.295

View more
  6 in total

Review 1.  Multimorbidity.

Authors:  Søren T Skou; Frances S Mair; Martin Fortin; Bruce Guthrie; Bruno P Nunes; J Jaime Miranda; Cynthia M Boyd; Sanghamitra Pati; Sally Mtenga; Susan M Smith
Journal:  Nat Rev Dis Primers       Date:  2022-07-14       Impact factor: 65.038

2.  Factors Associated with Health-Related Quality of Life among Older Adults in Rural South Korea Based on Ecological Model.

Authors:  Shinae Lee; So Hyoung Hong; Hye Young Song
Journal:  Int J Environ Res Public Health       Date:  2022-06-08       Impact factor: 4.614

3.  Improvement in Quality of Life through Self-Management of Mild Symptoms during the COVID-19 Pandemic: A Prospective Cohort Study.

Authors:  Ryuichi Ohta; Yoshinori Ryu; Chiaki Sano
Journal:  Int J Environ Res Public Health       Date:  2022-05-30       Impact factor: 4.614

4.  The Smiles of Older People through Recreational Activities: Relationship between Smiles and Joy.

Authors:  Ryuichi Ohta; Megumi Nishida; Nobuyasu Okuda; Chiaki Sano
Journal:  Int J Environ Res Public Health       Date:  2021-02-09       Impact factor: 3.390

5.  Trends and Disparities in Quality of Life Among Older Adults From 1998 to 2018 in China: A National Observational Study.

Authors:  Jue Liu; Jun Wang
Journal:  Front Med (Lausanne)       Date:  2022-01-28

6.  Multimorbidity in the elderly in China based on the China Health and Retirement Longitudinal Study.

Authors:  Xiaorong Guo; Benhua Zhao; Tianmu Chen; Bin Hao; Tao Yang; Huimin Xu
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.